Back to today’s briefing

Story perspectives

FDA Approves HIV Drug Amid Funding Cuts Crisis

6/19/2025

27 6

Summary

Story summary

The FDA's approval of Yeztugo, an injectable HIV prevention drug, comes at a critical time as U.S. AIDS funding faces drastic cuts under the Trump administration. In South Africa, the closure of clinics has left vulnerable individuals like Lebo without essential treatment, raising alarms among experts about a potential rise in new infections and jeopardizing hard-won progress against HIV.

1 of 1

Story summary

The FDA's approval of Yeztugo, an injectable HIV prevention drug, comes at a critical time as U.S. AIDS funding faces drastic cuts under the Trump administration. In South Africa, the closure of clinics has left vulnerable individuals like Lebo without essential treatment, raising alarms among experts about a potential rise in new infections and jeopardizing hard-won progress against HIV.